Key challenges and future opportunities for LNP-based delivery

Nucleic Acid Insights 2024; 1(3), 121–125

DOI: 10.18609/nai.2024.017

Published: 19 March
Julien Couture-Senécal

Lipid nanoparticles (LNPs) face a number of hurdles, including diverse challenges and considerations around safety, efficiency, and freedom to operate. David McCall, Senior Editor, BioInsights, talks to Julien Couture-Senécal, Co-Founder and Director of Azane Therapeutics, about the key remaining questions surrounding LNPs as they continue to gain traction in the nucleic acid delivery space and beyond.